Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)

• Company Description    GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. Number of Employees: 777

• Price / Volume Information    Yesterday's Closing Price: $7.50 Daily Weekly Monthly 20 Day Moving Average: 3,435,484 shares Shares Outstanding: 396.46 (millions) Market Capitalization: $2,973.43 (millions) Beta: 0.29 52 Week High: $48.05 52 Week Low: $7.33 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -52.01% -49.17% 12 Week -55.20% -51.05% Year To Date -77.05% -72.25%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2701 OLYMPIC BOULEVARD - SANTA MONICA,CA 90404 USA ph: 855-268-2822 fax: - wnotaro@goodrx.com http://www.goodrx.com

• General Corporate Information    Officers Douglas Hirsch - Co-Chief Executive Officer Trevor Bezdek - Co-Chief Executive Officer Karsten Voermann - Chief Financial Officer Christopher Adams - Director Julie Bradley - Director Peer Information GoodRx Holdings, Inc. (CHCR) GoodRx Holdings, Inc. (ESRX) GoodRx Holdings, Inc. (MYDP) GoodRx Holdings, Inc. (GBCS) GoodRx Holdings, Inc. (LAXAF) GoodRx Holdings, Inc. (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 38246G108 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 396.46 Most Recent Split Date: (:1) Beta: 0.29 Market Capitalization: $2,973.43 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.10 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 16.17% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: 72.58 Trailing 12 Months: 250.00 PEG Ratio: 4.49 Price Ratios Price/Book: 3.78 Price/Cash Flow: 64.20 Price / Sales: 3.77 EPS Growth vs. Year Ago Period: 400.00% vs. Previous Quarter: 200.00% Sales Growth vs. Year Ago Period: 26.74% vs. Previous Quarter: -4.65% ROE 03/31/22 - 2.86 12/31/21 - 0.06 09/30/21 - -31.61 ROA 03/31/22 - 1.48 12/31/21 - 0.03 09/30/21 - -16.01 Current Ratio 03/31/22 - 16.76 12/31/21 - 13.42 09/30/21 - 14.47 Quick Ratio 03/31/22 - 16.76 12/31/21 - 13.42 09/30/21 - 14.47 Operating Margin 03/31/22 - 2.99 12/31/21 - 0.06 09/30/21 - -36.08 Net Margin 03/31/22 - -1.86 12/31/21 - -3.39 09/30/21 - -41.36 Pre-Tax Margin 03/31/22 - 1.86 12/31/21 - -1.37 09/30/21 - -46.91 Book Value 03/31/22 - 1.98 12/31/21 - 2.08 09/30/21 - 2.12 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.83 12/31/21 - 0.79 09/30/21 - 0.78 Debt-to-Capital 03/31/22 - 45.43 12/31/21 - 44.09 09/30/21 - 43.70

Powered by Zacks Investment Research ©